Literature DB >> 23331717

Altering the therapeutic paradigm towards a distal bowel margin of < 1 cm in patients with low-lying rectal cancer: a systematic review and commentary.

L Pahlman1, K Bujko, A Rutkowski, W Michalski.   

Abstract

AIM: The 1-cm rule of distal bowel clearance in patients with low-lying rectal cancer undergoing anterior resection is based mainly on pathological data showing distal intramural spread. Because clinical data are contradictory, a review that includes only cancers located ≤ 5 or ≤ 6 cm from the anal verge was carried out.
METHOD: A systematic review of the literature identified seven studies that presented results in relation to a margin of ≤ 1 cm (n = 293) vs > 1 cm (n = 315). In six studies, pre- or postoperative radiotherapy was implemented, and in one study patients were treated with surgery alone. Three studies, all implementing radiotherapy, reported results related to a margin of ≤ 5 mm (n = 51) vs > 5 mm (n = 125).
RESULTS: In none of the studies were the differences in local recurrence rate between the small and large margin groups statistically significant. The pooled analysis of six studies, in which patients received perioperative radiotherapy, showed a 1.2% [95% confidence interval (Cl) -4.5-7.0%] higher local recurrence rate in the ≤ 1 cm margin group compared with the > 1 cm margin group (P = 0.6). The corresponding figures for the ≤ 5 mm cut-off point were 0.5% (95% CI -7.6-8.7%, P = 0.9). The 5-year local recurrence rate in the only study in which radiotherapy had not been used was 8.6% higher in the ≤ 1 cm margin group compared with the > 1 cm margin group (P = 0.09).
CONCLUSION: Clinical evidence does not support the 1-cm rule in patients with low-lying rectal cancer undergoing pre- or postoperative radiotherapy.
© 2013 The Authors. Colorectal Disease © 2013 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Mesh:

Year:  2013        PMID: 23331717     DOI: 10.1111/codi.12120

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  6 in total

Review 1.  Intersphincteric Resection Pushing the Envelope for Sphincter Preservation.

Authors:  Quentin Denost; Eric Rullier
Journal:  Clin Colon Rectal Surg       Date:  2017-11-27

2.  Total mesorectal excision for mid and low rectal cancer: Laparoscopic vs robotic surgery.

Authors:  Francesco Feroci; Andrea Vannucchi; Paolo Pietro Bianchi; Stefano Cantafio; Alessia Garzi; Giampaolo Formisano; Marco Scatizzi
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

3.  Comparative analysis focusing on surgical and early oncological outcomes of open, laparoscopy-assisted, and robot-assisted approaches in rectal cancer patients.

Authors:  Jin Cheon Kim; Chang Sik Yu; Seok-Byung Lim; In Ja Park; Chan Wook Kim; Yong Sik Yoon
Journal:  Int J Colorectal Dis       Date:  2016-04-15       Impact factor: 2.571

4.  Reduced luminal circumference of tumors plays a key role in anorectal function during the early period after neoadjuvant chemoradiation therapy in rectal cancer patients.

Authors:  Bong-Hyeon Kye; Hyung-Jin Kim; Hyeon-Min Cho; Jun-Gi Kim; Sung Hwan Kim; Byoung-Yong Shim
Journal:  Int J Colorectal Dis       Date:  2015-02-25       Impact factor: 2.571

5.  The Influence of the Distal Resection Margin Length on Local Recurrence and long- term Survival in Patients with Rectal Cancer after Chemoradiotherapy and Sphincter- Preserving Rectal Resection.

Authors:  Jan Grosek; Vaneja Velenik; Ibrahim Edhemovic; Mirko Omejc
Journal:  Radiol Oncol       Date:  2016-05-24       Impact factor: 2.991

6.  Survival analysis of local excision vs total mesorectal excision for middle and low rectal cancer in pT1/pT2 stage and intermediate pathological risk.

Authors:  I-Li Lai; Jeng-Fu You; Yih-Jong Chern; Wen-Sy Tsai; Jy-Ming Chiang; Pao-Shiu Hsieh; Hsin-Yuan Hung; Chien-Yuh Yeh; Sum-Fu Chiang; Cheng-Chou Lai; Rei-Ping Tang; Jinn-Shiun Chen; Yu-Jen Hsu
Journal:  World J Surg Oncol       Date:  2019-12-09       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.